SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-22-002569
Filing Date
2022-01-28
Accepted
2022-01-28 16:54:49
Documents
15
Period of Report
2022-01-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 43638
2 ex1-1.htm EX-1.1 258445
3 ex5-1.htm EX-5.1 23260
4 ex5-1_001.jpg GRAPHIC 4949
  Complete submission text file 0001493152-22-002569.txt   571177

Data Files

Seq Description Document Type Size
5 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ghsi-20220128.xsd EX-101.SCH 2767
6 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ghsi-20220128_lab.xml EX-101.LAB 34476
7 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ghsi-20220128_pre.xml EX-101.PRE 22607
9 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3730
Mailing Address 2925 RICHMOND AVENUE SUITE 1200 HOUSTON TX 77098
Business Address 2925 RICHMOND AVENUE SUITE 1200 HOUSTON TX 77098 (800) 873-5141
Guardion Health Sciences, Inc. (Filer) CIK: 0001642375 (see all company filings)

IRS No.: 474428421 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38861 | Film No.: 22569689
SIC: 2834 Pharmaceutical Preparations